Effect of sildenafil added to antifibrotic treatment in idiopathic pulmonary fibrosis
Abstract Sildenafil is a phosphodiesterase-5 inhibitor used to treat idiopathic pulmonary arterial hypertension; however, its benefits are unclear in patients with advanced idiopathic pulmonary fibrosis (IPF). We aimed to evaluate its effect as an add-on to antifibrotic agents on clinical outcomes o...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/98744e44e4c2472da78b957c76dcc9cc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|